Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-23T21:40:17.000Z Has data issue: false hasContentIssue false

The role of integrin beta in schizophrenia: a preliminary exploration

Published online by Cambridge University Press:  24 October 2022

Binshan He
Affiliation:
Department of Blood Transfusion, The Affiliated Hospital of Southwest Medical University, Luzhou, China
Yuhan Wang
Affiliation:
Department of Blood Transfusion, Ya’an People’s Hospital, Ya’an, China
Huang Li
Affiliation:
Department of Clinical Medicine, Southwest Medical University, Luzhou, China
Yuanshuai Huang*
Affiliation:
Department of Blood Transfusion, The Affiliated Hospital of Southwest Medical University, Luzhou, China
*
*Author for correspondence: Yuanshuai Huang Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Integrins are transmembrane heterodimeric (αβ) receptors that transduce mechanical signals between the extracellular milieu and the cell in a bidirectional manner. Extensive research has shown that the integrin beta (β) family is widely expressed in the brain and that they control various aspects of brain development and function. Schizophrenia is a relatively common neurological disorder of unknown etiology and has been found to be closely related to neurodevelopment and neurochemicals in neuropathological studies of schizophrenia. Here, we review literature from recent years that shows that schizophrenia involves multiple signaling pathways related to neuronal migration, axon guidance, cell adhesion, and actin cytoskeleton dynamics, and that dysregulation of these processes affects the normal function of neurons and synapses. In fact, alterations in integrin β structure, expression and signaling for neural circuits, cortex, and synapses are likely to be associated with schizophrenia. We explored several aspects of the possible association between integrin β and schizophrenia in an attempt to demonstrate the role of integrin β in schizophrenia, which may help to provide new insights into the study of the pathogenesis and treatment of schizophrenia.

Type
Review
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Introduction

Integrins are heterodimeric (αβ) extracellular matrix (ECM) receptors that mediate cell-matrix and cell-cell adhesion. Integrin β is an essential subunit in heterodimers, and eight different β subunits have been identified that can form a variety of integrin αβ heterodimer combinations with different α subunits, which are important in the developmental maturation of the nervous system. In particular, integrins containing β1 and β3 subunits have been most studied. β-class integrins are closely associated with synapses and play a critical role in the regulation of synaptic function. Integrin β family members also regulate a variety of neurotransmitters, hormones, and protein peptides, such as serotonin (5-HT), glutamate, estrogen, and neurotrophic factors.

Schizophrenia is a polygenic disorder characterized by psychosis, apathy, social withdrawal, and cognitive impairment.Reference Mueser and McGurk 1 It consists of three types of symptoms, negative, positive, and cognitive.Reference Birnbaum and Weinberger 2 Its etiology is currently unknown, but it is associated with developmental processes in the brain and multiple neurotransmitters in the brain, and several different hypotheses have been proposed, including neurodevelopmental and neurochemical hypotheses.Reference Birnbaum and Weinberger 2 Due to the pathogenesis of schizophrenia remains unclear, its treatment presents many challenges.

In schizophrenia-related studies, despite growing evidence of an association between integrin β and schizophrenia, it remains difficult to understand why and how altered integrin β adhesion and signaling can lead to the onset or development of schizophrenia. Here, we discuss the evidence linking integrin β to schizophrenia. We focus on common mechanisms and recurrent signaling pathways in an attempt to connect the dots between integrin β molecular structure, signaling, synaptic function, and schizophrenia and to suggest clinical ideas for exploring the pathogenesis of schizophrenia and studying the treatment related to integrin β and schizophrenia.

Integrin β and DISC1

In earlier years, a study found significantly increased expression of platelet integrin αIIbβIIIa in drug-naive, first-episode schizophrenic patients by comparison with healthy controls.Reference Walsh, Ryan, Hillmann, Condren, Kenny, Dinan and Thakore 3 Subsequently, another study identified polymorphisms in the integrin β3 gene (ITGB3) associated with the age of onset of schizophrenia through statistical analysis of big data.Reference Wang, Liu, Arana, Thompson, Weisman, Devargas, Mao, Su, Camarillo, Escamilla and Xu 4 Disrupted-in-schizophrenia 1 (DISC1) is a major psychiatric disease susceptibility gene associated with the molecular mechanisms of schizophrenia,Reference Matsuzaki and Tohyama 5 and it is involved in many critical neurodevelopmental processes, including neurite growth, neuronal migration, and differentiation.Reference Enomoto, Asai, Namba, Wang, Kato, Tanaka, Tatsumi, Taya, Tsuboi, Kuroda, Kaneko, Sawamoto, Miyamoto, Jijiwa, Murakumo, Sokabe, Seki, Kaibuchi and Takahashi 6 - Reference Miyoshi, Honda, Baba, Taniguchi, Oono, Fujita, Kuroda, Katayama and Tohyama 8 In which, it has been shown that DISC1 regulates cell adhesion by increasing the expression of integrin β1, which promotes neurite growth.Reference Hattori, Shimizu, Koyama, Yamada, Kuwahara, Kumamoto, Matsuzaki, Ito, Katayama and Tohyama 7 Therefore, integrin β can be linked to schizophrenia through DISC1. Integrin β has also been associated with several symptoms of schizophrenia. Integrin β3 knockout mice exhibit diminished preference for social novelty in a novel environment, increased repetitive behaviorReference Carter, Shah, Muller, Crawley, Carneiro and Weele J 9 as well as abnormal anxiety-like behavior,Reference McGeachie, Skrzypiec, Cingolani, Letellier, Pawlak and Goda 10 exaggerated vulnerability under chronic unpredictable stress, and changes in midbrain synaptophysin and dopamine metabolism,Reference Varney, Polston, Jessen and Carneiro 11 which are similar to some of the symptoms present in schizophrenia.

Integrin β and synapses

The function of synapses, that is, the connections between neurons, is important for brain function. Abnormalities in synaptic transmission and plasticity during neural development can lead to the development of schizophrenia.Reference Mirnics, Middleton, Lewis and Levitt 12 - Reference Stephan, Baldeweg and Friston 15 And disruption of the glutamatergic signaling pathways associated with synaptic plasticity has also been linked to the etiology of schizophrenia.Reference Pocklington, O’Donovan and Owen 16 In addition, schizophrenia susceptibility genes that play key roles in synaptic function,Reference Yin, Chen, Sathyamurthy, Xiong and Mei 17 such as D2 dopamine receptor (D2 DR), DISC1, neuregulin 1 (NRG1) and its receptor ErbB4, and voltage-gated calcium channels (VGCC) associated with schizophrenia etiology, have been widely reported for their regulation of synaptic plasticity and also interact with postsynaptic N-methyl-D-aspartate acid receptor (NMDAR).Reference Moosmang, Haider, Klugbauer, Adelsberger, Langwieser, Müller, Stiess, Marais, Schulla, Lacinova, Goebbels, Nave, Storm, Hofmann and Kleppisch 18

Not surprisingly, the close association between synapses and schizophrenia is described above, and integrin β is also known to play an important part in synapses (Figure 1). β1 integrins are essential for synapse formation,Reference Nikonenko, Toni, Moosmayer, Shigeri, Muller and Sargent Jones 19 and β1 integrins that aggregate post-synaptically can also function as adhesion proteins to mediate synaptic adhesion.Reference Mortillo, Elste, Ge, Patil, Hsiao, Huntley, Davis and Benson 20 In hippocampal CA1 pyramidal neurons, ablation of α3 or β1 integrins at specific times during embryonic and postnatal life respectively affects the structure and function of excitatory synapses.Reference Kerrisk, Greer and Koleske 21 - Reference Chan, Weeber, Zong, Fuchs, Sweatt and Davis 24 α3β1 integrin regulates synaptic and dendritic stability by binding to the ECM protein laminin α5,Reference Omar, Kerrisk Campbell, Xiao, Zhong, Brunken, Miner, Greer and Koleske 25 and intracellularly it interacts with and activates the Abl2/Arg (Abl-related gene) non-receptor tyrosine kinase, thereby affecting actin remodeling in dendrites and spines.Reference Kerrisk, Greer and Koleske 21 , Reference Warren, Bradley, Gourley, Lin, Simpson, Reichardt, Greer, Taylor and Koleske 22 , Reference Lin, Yeckel and Koleske 26 - Reference Simpson, Bradley, Harburger, Parsons, Calderwood and Koleske 28 β3 integrins affect synaptic strength by regulating the quantal size and content of excitatory synaptic transmission.Reference Cingolani and Goda 29 , Reference Pozo, Cingolani, Bassani, Laurent, Passafaro and Goda 30 Integrin β also modulates synaptic plasticity. Synaptic plasticity in the adult hippocampus requires β1 integrins,Reference Chan, Weeber, Zong, Fuchs, Sweatt and Davis 24 but β3 integrin is dispensable for Hebbian forms of plasticity in the hippocampus.Reference McGeachie, Skrzypiec, Cingolani, Letellier, Pawlak and Goda 10 β1 class integrins also affect neuronal cytoplasmic calcium levels, thereby modulating the lasting synaptic plasticity in forebrain neurons.Reference Lin, Hilgenberg, Smith, Lynch and Gall 31 Postsynaptic plasticity-related gene 1 (PRG-1) also affects synaptic plasticity in a cell-autonomous fashion by activating integrin β1.Reference Liu, Huai, Endle, Schlüter, Fan, Li, Richers, Yurugi, Rajalingam, Ji, Cheng, Rister, Horta, Baumgart, Berger, Laube, Schmitt, Schmeisser, Boeckers, Tenzer, Vlachos, Deller, Nitsch and Vogt 32 Long-term potentiation (LTP) is a form of synaptic plasticity, and deletion of β1 integrins impairs LTP,Reference McGeachie, Skrzypiec, Cingolani, Letellier, Pawlak and Goda 10 , Reference Huang, Shimazu, Woo, Zang, Müller, Lu and Reichardt 33 and in recent years it has also been shown that β1 integrins are involved in a novel form of cognition-related LTP triggered by endocannabinoid signaling in the hippocampus.Reference Wang, Jia, Pham, Palmer, Jung, Cox, Rumbaugh, Piomelli, Gall and Lynch 34 Synaptic homeostasis is also a form of synaptic plasticity, and β3 integrins are required in homeostatic plasticity.Reference Cingolani and Goda 29 In addition, integrins composed of β1 and α3 subunits are involved in the regulation of inhibitory synaptic plasticity.Reference Kawaguchi and Hirano 35 Thus, alterations of integrin β activation and adhesion might therefore underlie some of the structural defects found in schizophrenic patients.

Figure 1. The association among integrin β, schizophrenia, and synapses.

Talin and Kindlin act as integrin activators, binding to the cytoplasmic tail of the integrin β subunits thereby activating integrins. LTP is a form of synaptic plasticity, and LTP induction mechanisms require synaptic NMDAR activation and Ca2+ influx to participate in downstream signaling cascades, whereas β1 integrin deficiency impairs LTP; therefore, it can be assumed that β1 integrin has a key role in NMDAR-dependent LTP-induced downstream signaling pathways.Reference Park and Goda 36 PRG-1 affects synaptic plasticity in a cell-autonomous manner by activating integrin β1.Reference Liu, Huai, Endle, Schlüter, Fan, Li, Richers, Yurugi, Rajalingam, Ji, Cheng, Rister, Horta, Baumgart, Berger, Laube, Schmitt, Schmeisser, Boeckers, Tenzer, Vlachos, Deller, Nitsch and Vogt 32 β1 integrin is also involved in a novel form of cognition-related LTP triggered by endogenous cannabinoid signaling in the hippocampus.Reference Wang, Jia, Pham, Palmer, Jung, Cox, Rumbaugh, Piomelli, Gall and Lynch 34 β3 integrins control synaptic strength by influencing alpha-amino-3-hydroxy-5-methylisoxazole-4-proprionate receptor (AMPAR). Under basal activity conditions, β3 integrins promote the internalization of GluA2-containing AMPAR, and after chronic activity stripping, β3 integrins are recruited to the cell surface via postsynaptic tumor necrosis factor signaling.Reference Pozo, Cingolani, Bassani, Laurent, Passafaro and Goda 30 The green shaded section contains schizophrenia susceptibility genes (D2 DR, DISC1, NRG1, and ErbB4), which affect synaptic function in multiple ways. Of these, NRG1 can promote GABA release and thus inhibit LTP.Reference Chen, Zhang, Yin, Wen, Ting, Wang, Lu, Zhu, Li, Wu, Wang, Lai, Xiong, Mei and Gao 37 - Reference Wen, Lu, Zhu, Li, Woo, Chen, Yin, Lai, Terry, Vazdarjanova, Xiong and Mei 40 VGCC can interact with postsynaptic NMDARReference Moosmang, Haider, Klugbauer, Adelsberger, Langwieser, Müller, Stiess, Marais, Schulla, Lacinova, Goebbels, Nave, Storm, Hofmann and Kleppisch 18 and regulate synaptic plasticity.

Neuroanatomy of integrin β associated with schizophrenia

Most studies of schizophrenics reveal decreased volume of multiple structures in the brain.Reference Bogerts, Meertz and Schönfeldt-Bausch 41 - Reference Wong and Van Tol 44 One study showed a significant reduction in intracranial and total brain volume of 2.0% and 2.6% in medicated schizophrenia patients by meta-analysis.Reference Haijma, Van Haren, Cahn, Koolschijn, Hulshoff Pol and Kahn 45 β integrins also affect brain volume. Granule cell precursors in the cerebellum of mice with a central nervous system-restricted knockout of the integrin β1 subunit gene stop proliferating and differentiate prematurely, leading to a reduction in the final number of mature granule cells, as well as a reduction in cerebellar size.Reference Blaess, Graus-Porta, Belvindrah, Radakovits, Pons, Littlewood-Evans, Senften, Guo, Li, Miner, Reichardt and Müller 46 Analysis of an ITGβ3 homozygous knockout mouse using MRI imaging revealed an 11% reduction in total brain volume.Reference Ellegood, Henkelman and Lerch 47 Integrin β3 homozygous knockout mice associated with autism also had significantly smaller cerebellum than wild-type mice, with 28 out of 39 cerebellar structures smaller.Reference Steadman, Ellegood, Szulc, Turnbull, Joyner, Henkelman and Lerch 48

Schizophrenia is associated with cortical thickness. Study finds cortical thinning in schizophrenia patients by high-resolution MRI imaging.Reference Xie, Zhang, Tang, Zhang, Yu, Gong, Wang, Evans, Zhang and He 49 , Reference Planchuelo-Gómez, Lubeiro, Núñez-Novo, Gomez-Pilar, de Luis-García, Del Valle, Martín-Santiago, Pérez-Escudero and Molina 50 During cortical development, multiple β-integrins are expressed in the cortex and are closely associated with cortical formation and plasticityReference Schmid and Anton 51 (Table 1). β1 and β5 integrins are widely expressed and persist in the cerebral cortex,Reference Cousin, Leloup, Pénicaud and Price 52 , Reference Pinkstaff, Detterich, Lynch and Gall 53 β6 integrin is expressed in adult cortical primarily on neurons and oligodendrocytes,Reference Cousin, Leloup, Pénicaud and Price 52 and β8 is widely distributed throughout the neuropil.Reference Nishimura, Boylen, Einheber, Milner, Ramos and Pytela 54 Mice lacking β1 integrin have impaired cerebral and cerebellar cortex development, resulting in abnormal cortical neuronal positioning and defects in the laminar structure of the cerebral and cerebellar cortex,Reference Graus-Porta, Blaess, Senften, Littlewood-Evans, Damsky, Huang, Orban, Klein, Schittny and Müller 55 and removal of β1 integrin at the embryonic stage in mice also results in severe cortical lamination defects.Reference Huang, Shimazu, Woo, Zang, Müller, Lu and Reichardt 33 β1 integrin and laminin-mediated glial-meningeal adhesive interactions are closely associated with the normal assembly of the cerebral cortex.Reference Milner and Campbell 56

Table 1. Distribution and Function of Integrin β in the Cerebral Cortex and Phenotype of Integrin β Subunit Deficient Mice

a Not phenotypes associated with schizophrenia.

Dysfunctional dendrites are a key feature of many developmental neurological disorders. Dendrites in prefrontal cortex (PFC) pyramidal cells are hypodense and small in schizophrenia. β integrins can also affect dendritic and axonal function. Study shows that neuronal α7β1 integrin can mediate neurite growth in the alternatively spliced region of human Tenascin-C.Reference Mercado, Nur-e-Kamal, Liu, Gross, Movahed and Meiners 57 Integrins can regulate actin reorganization in dendritic spines through NMDAR, thereby affecting dendritic spine plasticity.Reference Shi and Ethell 58 Integrin β1 can regulate the size and complexity of hippocampal dendritic arbors through the β1- Arg-p190RhoGAP signaling cascade.Reference Warren, Bradley, Gourley, Lin, Simpson, Reichardt, Greer, Taylor and Koleske 22 Integrin β1 also interacts with intercellular adhesion molecule-5 (ICAM-5) by regulating the ectodomain cleavage of ICAM-5, which in turn regulates dendritic spine morphology and synaptic maturation.Reference Ning, Tian, Smirnov, Vihinen, Llano, Vick, Davis, Rivera and Gahmberg 59 Integrin β3 organizes dendritic complexity of cerebral cortical pyramidal neurons along a tangential gradient.Reference Swinehart, Bland, Holley, Lopuch, Casey, Handwerk and Vidal 60

Integrin β associated with neurotransmitters in schizophrenia

Neurotransmitters have been the most active area of research on the etiology of schizophrenia. It has been shown earlier that platelet glutamate receptors may be hypersensitive in schizophrenic patients,Reference Berk, Plein and Csizmadia 75 and the results support decreased glutamate function in schizophrenia.Reference Kim, Kornhuber, Schmid-Burgk and Holzmüller 76 , Reference Tsai, Passani, Slusher, Carter, Baer, Kleinman and Coyle 77 Several studies have shown that neurotransmitters such as dopamine, serotonin, and glutamate are involved in the development of schizophrenia.Reference Howes and Kapur 78 - Reference Zamanpoor 81 Some symptoms of schizophrenia may be due to hypofunction of NMDARs, especially in the PFC.Reference Balu 82 In addition, metabotropic glutamate (mGlu) receptors have long been used as important therapeutic targets for schizophrenia.Reference Vinson and Conn 83 - Reference Dogra and Conn 85 It has recently been shown that ITGB3, the gene encoding the ECM receptor integrin β3, can interact with mGluR5 to regulate the functional expression of synaptic mGluR5 and directly affect neuronal excitability.Reference Jaudon, Thalhammer, Zentilin and Cingolani 86 Neurotransmitter imbalances play an important role in cognitive deficits in schizophrenia,Reference Clegg, Wingerd, Hikita and Tolhurst 87 and depression and anxiety are also associated with imbalances in central nervous system 5-HT levels. And there is a close link between integrin β and several of those neurotransmitters.

Integrin β regulates glutamate

NMDARs and AMPARs are subtypes of ionotropic glutamate receptors, and mice with reduced NMDA receptor expression exhibit manifestations similar to schizophrenia.Reference Mohn, Gainetdinov, Caron and Koller 88 Integrins can exert regulation of synaptic NMAD-type glutamate receptor operation by activating Src kinase,Reference Lin, Arai, Lynch and Gall 89 and the activated local kinase cascade response enhances the function of synaptic NMDA receptors in the mature hippocampus, a response that is closely associated with β1 integrins.Reference Bernard-Trifilo, Kramár, Torp, Lin, Pineda, Lynch and Gall 90 The interplay between Reelin and β1 integrins is required also for the developmental switch in NMDAR subunit composition from GluN2B to GluN2A.Reference Jaudon, Thalhammer and Cingolani 91 - Reference Iafrati, Orejarena, Lassalle, Bouamrane, Gonzalez-Campo and Chavis 93 AMPA-type glutamate receptor activation increases α5 and β1 integrin surface expression, adhesive function, and signaling.Reference Lin, Lynch and Gall 94 Postsynaptic β3 integrins directly interact with GluA2 AMPAR subunits through their respective C-termini and regulate AMPAR abundance and composition to control synaptic strength.Reference Pozo, Cingolani, Bassani, Laurent, Passafaro and Goda 30 , Reference Cingolani, Thalhammer, Yu, Catalano, Ramos, Colicos and Goda 95 β1 integrins and ERK1/2 can mediate astrocyte-derived Pentraxin 3 (PTX3)-induced recruitment of synaptic AMPA glutamate receptors, thereby promoting synaptic maturation.Reference Fossati, Pozzi, Canzi, Mirabella, Valentino, Morini, Ghirardini, Filipello, Moretti, Gotti, Annis, Mosher, Garlanda, Bottazzi, Taraboletti, Mantovani, Matteoli and Menna 96 Binding of β1 integrin to vascular cell adhesion molecule 1 triggers glutamine, which stimulates glutamate release from Th17 cells.Reference Birkner, Wasser, Ruck, Thalman, Luchtman, Pape, Schmaul, Bitar, Krämer-Albers, Stroh, Meuth, Zipp and Bittner 97

Integrin β regulates 5-HT

There is a strong association between β-integrin and whole blood serotonin levels, genomic scans identified ITGB3 (encoding integrin β3) as a quantitative trait loci for whole blood serotonin,Reference Weiss, Veenstra-Vanderweele, Newman, Kim, Dytch, MS, Cheng, Ober, Cook and Abney 98 and common variation in ITGB3 is associated with serotonin concentrated in males.Reference Weiss, Abney, Parry, Scanu, Cook and Ober 99 A strong association between single-nucleotide polymorphisms (SNPs) in ITGB3 and serotonin levels was found in two outbred samples,Reference Weiss, Kosova, Delahanty, Jiang, Cook, Ober and Sutcliffe 100 after which experiments showed that it was the SNP rs2317385, located at the 5’ end of the ITGB3 gene, that significantly influenced 5-HT blood levels.Reference Napolioni, Lombardi, Sacco, Curatolo, Manzi, Alessandrelli, Militerni, Bravaccio, Lenti, Saccani, Schneider, Melmed, Pascucci, Puglisi-Allegra, Reichelt, Rousseau, Lewin and Persico 101 ITGB3 haplotypes were also significantly associated with the distribution of platelet serotonin levels.Reference Coutinho, Sousa, Martins, Correia, Morgadinho, Bento, Marques, Ataíde, Miguel, Moore, Oliveira and Vicente 102

The transporter protein of 5-hydroxytryptamine (SERT) is a membrane protein that transports 5HT from the synaptic gap to presynaptic neurons, and knockout mice lacking integrin β3 showed reduced platelet SERT activity.Reference Carneiro, Cook, Murphy and Blakely 103 SLC6A4 is the gene encoding the 5-HT transporter, and it has been demonstrated through open genomic resources that the expression of SLC6A4 and ITGB3 is correlated in several tissues in humans and mice.Reference Weiss, Ober and Cook 104 The 5-HT transporter and integrin β3 genes interact to regulate 5-HT uptake in the mouse central nervous system.Reference Whyte, Jessen, Varney and Carneiro 105 Changes in integrin β3 subunit expression can also regulate the rate of SERT-mediated 5-HT transport.Reference Mazalouskas, Jessen, Varney, Sutcliffe, Veenstra-Vander Weele, Cook and Carneiro 106 In recent years, a study has shown an important association between integrin β and both neuropsychiatric disorders by using knock-in mice of the Itgb3 variant to phenocopies the human Pro33 variant, which produces hyperactive αvβ3 receptors in mice, and found decreased 5-HT system function and multiple behavioral deficits in mice.Reference Dohn, Kooker, Bastarache, Jessen, Rinaldi, Varney, Mazalouskas, Pan, Oliver, Velez Edwards, Sutcliffe, Denny and Carneiro 107 In a study based on samples from patients with autism spectrum disorder, the promoter variant rs55827077 of ITGB3 was found to increase platelet integrin β3 protein expression and elevated blood levels of 5-HT.Reference Gabriele, Canali, Lintas, Sacco, Tirindelli, Ricciardello and Persico 108 Integrin β3 is also associated with a mode of action with selective serotonin reuptake inhibitors (SSRIs) antidepressants,Reference Oved, Morag, Pasmanik-Chor, Rehavi, Shomron and Gurwitz 109 and reduced expression of integrin β3 subunits reduces the effective dose of SSRIs by affecting the population size of active SERT molecules.Reference Mazalouskas, Jessen, Varney, Sutcliffe, Veenstra-Vander Weele, Cook and Carneiro 106

Integrin β and BDNF

Brain-derived neurotrophic factor (BDNF) is a secreted peptide that is widely expressed in the nervous system and plays a key role in neuronal survival and synaptic plasticity. The role played by BDNF in schizophrenia has been extensively studied, and many studies have shown that serum BDNF levels are lower in schizophrenic patientsReference Turkmen, Yazici, Erdogan, Suda and Yazici 110 - Reference Vinogradov, Fisher, Holland, Shelly, Wolkowitz and Mellon 116 except that a few studies have found higher BDNF levels,Reference Gama, Andreazza, Kunz, Berk, Belmonte-de-Abreu and Kapczinski 117 , Reference Reis, Nicolato, Barbosa, Teixeira do Prado, Romano-Silva and Teixeira 118 but what can be confirmed is that BDNF levels are altered in patients with schizophrenia.Reference Favalli, Li, Belmonte-de-Abreu, Wong and Daskalakis 119 , Reference Pandya, Kutiyanawalla and Pillai 120 Meta-analysis demonstrated a firm correlation between serum BDNF levels and the course of severe schizophrenia and major depression, suggesting that BDNF is a potential circulating biomarker for schizophrenia or depression.Reference Peng, Li, Lv, Zhang and Zhan 121 In recent years, studies have supported that serum BDNF levels are lower in patients with first-episode schizophrenia than in healthy controlsReference Singh, Verma, Raghav, Sarkar, Sood and Jain 122 , Reference Li, Chen, Xiu, Li and Zhang 123 and that abnormal signaling of BDNF increases an individual’s susceptibility to schizophrenia by affecting brain function.Reference Singh, Verma, Raghav, Sarkar, Sood and Jain 122 Lower BDNF levels are also associated with decreased cognitive performance in schizophrenia subjects.Reference Hori, Yoshimura, Katsuki, Atake, Igata, Konishi and Nakamura 124 , Reference Yang, Liu, Wang, Hei, Wang, Li, Li, Wu and Zhao 125

The relationship between integrin β and BDNF has not been well documented by research, but a few studies have indicated an association. Integrins bound to arginine-glycine-aspartate (RGD) matrix sequences can increase the expression of mRNAs for BDNF and its receptors TrkB and TrkC in hippocampal slices through effects on voltage-sensitive calcium channels, and although the specific integrin involved is unclear, it is likely to be related to integrin β1.Reference Gall, Pinkstaff, Lauterborn, Xie and Lynch 126 Neurotrophins promote the survival of newborn hippocampal neurons by promoting spontaneous GABA-dependent activity, and this survival effect requires integrin β1 signaling.Reference Murase, Owens and McKay 127 Integrin β1 is also involved in signaling of the glial cell line-derived neurotrophic factor (GDNF) and may function as a signaling receptor for GDNF.Reference Cao, Yu, Li, Sun, Yuan, Wang and Gao 128

Integrin β and estrogen

Estrogen can function in schizophrenia by modulating the excitatory transmitter glutamate (Figure 2). In cultured hippocampal neurons, estrogen enhances glutamate release from presynaptic sites through activation of phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK).Reference Yokomaku, Numakawa, Numakawa, Suzuki, Matsumoto, Adachi, Nishio, Taguchi and Hatanaka 129 Several studies have shown that 17 β-estradiol (E2) enhances glutamatergic synaptic transmission in the hippocampus through mechanisms that increase presynaptic glutamate release probabilityReference Smejkalova and Woolley 130 , Reference Oberlander and Woolley 131 and postsynaptic sensitivity to glutamate.Reference Oberlander and Woolley 131 Estrogen and integrin β are tightly related in many ways. Estrogen’s effects on excitatory synaptic transmission entail transactivation of the BDNF receptors TrkB and β1 integrin, and β1 integrin function has a decisive role.Reference Wang, Kantorovich, Babayan, Hou, Gall and Lynch 132 Estradiol activates integrin α5β1 to promote the attachment of striatal neurons to fibronectin, and activated integrin α5β1 also contributes to synapse formation of human-induced pluripotent stem cell-derived dopaminergic (DA) neurons.Reference Nishimura, Doi, Samata, Murayama, Tahara, Onoe and Takahashi 133

Figure 2. Schematic representation of the mechanism by which estrogen affects glutamatergic synaptic transmission.

E2 binds to the estrogen receptor ER and activates the classical MAPK pathway, causing phosphorylation and activation of the MAPK kinase B-Raf, the MAPK kinases MEK1/2 and the ERK1/2. E2 activates the PI3K signaling pathway, causing activation of phosphoinositide-dependent kinases (PDK1/2) and subsequently AKT/protein kinase B.Reference Belcher and Zsarnovszky 139 Both signaling pathways can enhance glutamatergic synaptic transmission. The mechanisms involved include increased presynaptic glutamate release probabilityReference Smejkalova and Woolley 130 , Reference Oberlander and Woolley 131 and postsynaptic sensitivity to glutamate.Reference Oberlander and Woolley 131 In addition, E2 is involved in the activation of integrin β1 by acting on Src family kinases and Ras/Rap GTPases. Activated integrin β1 can drive downstream small GTPases that enable local polymerization of filamentous actin (F-actin) from actin monomers (G-actin), thereby affecting AMPAR. Activation of small GTPases can transactivate TrkB, and it has also been speculated that the aforementioned cytoskeletal reorganization also affects TrkB activation.Reference Wang, Kantorovich, Babayan, Hou, Gall and Lynch 132

Estrogen is additionally involved in the regulation of hippocampal synaptic plasticity.Reference Rune and Frotscher 134 - Reference Spencer-Segal, Tsuda, Mattei, Waters, Romeo, Milner, BS and Ogawa 136 Moreover, E2 acts as a novel neuromodulator in the forebrain, affecting synaptic plasticity and cognitive function.Reference Lu, Sareddy, Wang, Wang, Li, Dong, Zhang, Liu, O’Connor, Xu, Vadlamudi and Brann 137 Recently, it has been indicated that E2 receptor α induces a new form of LTP that is NMAD receptor dependent and involves AMPAR transport to the synapse.Reference Clements and Harvey 138

Integrin β and CHL1

Close homologue of L1 (CHL1) belongs to the immunoglobulin (Ig) superfamily cell adhesion molecules, a gene encoding neuronal cell adhesion protein that regulates the proliferation, migration, differentiation, and survival of neuronal cells.Reference Huang, Zhu, Zhao, Wu, Wu, Schachner, Xiao and Fan 140 - Reference Chen, Mantei, Dong and Schachner 142 CHL1 has been significantly associated with schizophrenia. Patients with schizophrenia present with timing impairmentsReference Braus 143 - Reference Volz, Nenadic, Gaser, Rammsayer, Häger and Sauer 146 as well as deficits in spatiotemporal integration,Reference Herzog and Brand 147 , Reference Velasques, Machado, Paes, Cunha, Sanfim, Budde, Cagy, Anghinah, Basile, Piedade and Ribeiro 148 and CHL1 knockout mice exhibit the same symptoms.Reference Buhusi, Scripa, Williams and Buhusi 149 Furthermore, the rs2272522 polymorphism of the CHL1 locus is significantly associated with schizophrenia in the Qatari population,Reference Shaltout, Alali, Bushra, Alkaseri, Jose, Al-Khainji, Saleh, Salama Dahir, Shaltout, Al-Abdullah and Rizk 150 and CHL1-deficient mice were also identified as a model for schizophrenia-like learning and attention impairments.Reference Buhusi, Obray, Guercio, Bartlett and Buhusi 151 Domestic studies have shown that CHL1 interacts with DISC1 to regulate the development of neurite outgrowth and that disruption of this interaction may contribute to increased risk of schizophrenia.Reference Ren, Zhao, Xu and Ye 152

Integrin β is tightly associated with CHL1 as well. CHL1 interacts with β1-containing integrins to potentiate integrin-mediated cell migration.Reference Buhusi, Midkiff, Gates, Richter, Schachner and Maness 153 A direct link between ITGB3 and CHL1 was postulated to be involved in the regulation of serotonin uptake.Reference Oved, Morag, Pasmanik-Chor, Rehavi, Shomron and Gurwitz 109 Subsequently, a significant correlation between the gene expression levels of CHL1 and ITGB3 in Munich Antidepressant Response Signature lymphoblastoid cell lines was found, supporting the connection between CHL1 and ITGB3.Reference Probst-Schendzielorz, Scholl, Efimkina, Ersfeld, Viviani, Serretti, Fabbri, Gurwitz, Lucae, Ising, Paul, Lehmann, Steffens, Crisafulli, Calabrò, Holsboer and Stingl 154

Integrin β and Reelin

Reelin is an ECM protein that is synthesized and secreted by cortical GABAergic interneurons and is involved in several aspects of brain development and function, such as neuronal migration, synaptogenesis, and synaptic plasticity. Several studies have shown that Reelin and its mRNA levels are significantly reduced in several brain regions in schizophrenia patients compared to controls,Reference Jaudon, Thalhammer and Cingolani 91 , Reference Impagnatiello, Guidotti, Pesold, Dwivedi, Caruncho, Pisu, Uzunov, Smalheiser, Davis, Pandey, Pappas, Tueting, Sharma and Costa 155 - Reference Sethi and Zaia 160 and that Reelin downregulation is accompanied by a downregulation of GAD67.Reference Guidotti, Grayson and Caruncho 158 , Reference Lubbers, Smit, Spijker and van den Oever 161 Reelin can be involved in the regulation of glutamatergic synaptic maturation and plasticity by regulating synaptic NMDA receptor subunit composition and surface transport.Reference Groc, Choquet, Stephenson, Verrier, Manzoni and Chavis 92 In addition, adult brain Reelin levels directly affect cognitive function and dendritic spine density.Reference Guidotti, Grayson and Caruncho 158

Integrin β is linked to Reelin in multiple aspects. α3β1 integrin interacts with Reelin to regulate neuronal migration and normal cortical lamination and promote neuronal adhesion to fibronectin.Reference Jaudon, Thalhammer and Cingolani 91 , Reference Sekine, Kawauchi, Kubo, Honda, Herz, Hattori, Kinashi and Nakajima 162 , Reference Dulabon, Olson, Taglienti, Eisenhuth, McGrath, Walsh, Kreidberg and Anton 163 The interaction among the amyloid precursor protein, Reelin, and α3β1 integrin promotes neurite outgrowth.Reference Hoe, Lee, Carney, Lee, Markova, Lee, Howell, Hyman, Pak, Bu and Rebeck 164 Reelin activates α5β1 integrin to affect the correct neuronal positioning in the mature cortex.Reference Sekine, Kawauchi, Kubo, Honda, Herz, Hattori, Kinashi and Nakajima 162 In addition, Reelin initiates a series of kinase cascade reactions to promote neurodevelopmental processes by directly binding to its receptors APOER2, VLDLR, and α3β1 integrin and activating the downstream adapter protein DAB1.Reference Lubbers, Smit, Spijker and van den Oever 161 , Reference Folsom and Fatemi 165

Integrin β and MMP9

Matrix metalloproteinase-9 (MMP9) is an extracellular protease that has been revealed in several studies to play a critical role in regulating hippocampal synaptic physiology, plasticity, and long-term memory.Reference Nagy, Bozdagi, Matynia, Balcerzyk, Okulski, Dzwonek, Costa, Silva, Kaczmarek and Huntley 166 , Reference Bozdagi, Nagy, Kwei and Huntley 167 It has been found that tissue inhibitor of matrix metalloproteinases-1, an endogenous inhibitor of MMP9, interacts with MMP9 to affect plasticity in the PFC,Reference Okulski, Jay, Jaworski, Duniec, Dzwonek, Konopacki, Wilczynski, Sánchez-Capelo, Mallet and Kaczmarek 168 and the dysfunction of the PFC is tightly associated with the development of psychiatric disorders such as schizophrenia.Reference Egan and Weinberger 169 , Reference Kalia 170 A later study found increased MMP9 activity in mild cognitive impairment and that MMP9 led to a decrease in mature nerve growth factor.Reference Bruno, Mufson, Wuu and Cuello 171 In addition, a functional-1562 C/T polymorphism of the MMP9 gene was found to be relevant in the pathogenesis of schizophrenia by comparison with healthy controls.Reference Rybakowski 172 , Reference Rybakowski, Skibinska, Kapelski, Kaczmarek and Hauser 173

In the study of the relationship between MMP9 and integrin β, it was found that MMP9-driven LTP requires the mediation of β1-containing integrins and the activation of their downstream coenzyme protein signaling pathways.Reference Wang, Bozdagi, Nikitczuk, Zhai, Zhou and Huntley 174 Furthermore, MMP9 mediates surface transport of NMDAR through an integrin β1-dependent pathway.Reference Michaluk, Mikasova, Groc, Frischknecht, Choquet and Kaczmarek 175 Taken together, the interaction between integrin β and MMP9 may have an important association with schizophrenia.

Discussion

A strong correlation between integrin β and schizophrenia can be demonstrated by linking the etiology and clinical symptoms of schizophrenia to the role of integrin β in neurodevelopment, transmitter regulation, signaling, and the role it plays in states of anxiety and stress. However, we lack experimental evidence, and the pathways or mechanisms through which integrin β is involved in the effects on schizophrenia are not well understood. To date, most of our knowledge of the β integrin family in the brain has been on β1- and β3-containing integrins, and there is a lack of adequate interpretation of the physiological role of other β integrin subtypes in specific circuit-related brain functions in different brain regions,Reference Park and Goda 36 and it is not clear whether these integrin subtypes are associated with schizophrenia or play a role in other brain disorders. In addition, the ECM ligands of integrins have been less studied, whereas alterations in the components of the ECM are important for brain function, and past clinical studies have demonstrated a correlation between abnormal ECM function and neuropsychiatric disorders with some degree of causality, one of the most prominent being schizophrenia. Therefore, the identification of the ECM ligand for integrin β is also helpful to study the correlation with schizophrenia. In conclusion, it remains much to be learned about the diverse functions of members of the β integrin family and the ways in which they are involved in the pathogenesis of schizophrenia, and investigating the role of different β subtypes in specific signaling pathways and potential ECM ligands could provide new clinical directions for studying the pathogenesis and treatment of schizophrenia.

Acknowledgments

This work was supported by the 2021 National Innovation and Entrepreneurship Training program for College Students in China (grant no. 202110632050).

Author Contributions

Methodology: H.L.; resources: B.H., H.L.; supervision: Y.W.; writing—original draft: B.H.; writing—review and editing: Y.W., Y.H.

Disclosure

Binshan He, Yuhan Wang, Huang Li, and Yuanshuai Huang do not have anything to disclose.

References

Mueser, KT, McGurk, SR. Schizophrenia. Lancet. 2004;363(9426):20632072.CrossRefGoogle ScholarPubMed
Birnbaum, R, Weinberger, DR. Genetic insights into the neurodevelopmental origins of schizophrenia. Nat Rev Neurosci. 2017;18(12):727740.CrossRefGoogle ScholarPubMed
Walsh, MT, Ryan, M, Hillmann, A, Condren, R, Kenny, D, Dinan, T, Thakore, JH. Elevated expression of integrin alpha(IIb) beta(IIIa) in drug-naïve, first-episode schizophrenic patients. Biol Psychiatry. 2002;52(9):874879.CrossRefGoogle Scholar
Wang, KS, Liu, X, Arana, TB, Thompson, N, Weisman, H, Devargas, C, Mao, C, Su, BB, Camarillo, C, Escamilla, MA, Xu, C. Genetic association analysis of ITGB3 polymorphisms with age at onset of schizophrenia. J Mol Neurosci. 2013;51(2):446453.CrossRefGoogle ScholarPubMed
Matsuzaki, S, Tohyama, M. Molecular mechanism of schizophrenia with reference to disrupted-in-schizophrenia 1 (DISC1). Neurochem Int. 2007;51(2-4):165172.CrossRefGoogle ScholarPubMed
Enomoto, A, Asai, N, Namba, T, Wang, Y, Kato, T, Tanaka, M, Tatsumi, H, Taya, S, Tsuboi, D, Kuroda, K, Kaneko, N, Sawamoto, K, Miyamoto, R, Jijiwa, M, Murakumo, Y, Sokabe, M, Seki, T, Kaibuchi, K, Takahashi, M. Roles of disrupted-in-schizophrenia 1-interacting protein girdin in postnatal development of the dentate gyrus. Neuron. 2009;63(6):774787.CrossRefGoogle ScholarPubMed
Hattori, T, Shimizu, S, Koyama, Y, Yamada, K, Kuwahara, R, Kumamoto, N, Matsuzaki, S, Ito, A, Katayama, T, Tohyama, M. DISC1 regulates cell-cell adhesion, cell-matrix adhesion and neurite outgrowth. Mol Psychiatry, 2010;15(8):798809.CrossRefGoogle ScholarPubMed
Miyoshi, K, Honda, A, Baba, K, Taniguchi, M, Oono, K, Fujita, T, Kuroda, S, Katayama, T, Tohyama, M. Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol Psychiatry. 2003;8(7):685694.CrossRefGoogle ScholarPubMed
Carter, MD, Shah, CR, Muller, CL, Crawley, JN, Carneiro, AM, Weele J, Veenstra-Vander. Absence of preference for social novelty and increased grooming in integrin β3 knockout mice: initial studies and future directions. Autism Res. 2011;4(1):5767.CrossRefGoogle ScholarPubMed
McGeachie, AB, Skrzypiec, AE, Cingolani, LA, Letellier, M, Pawlak, R, Goda, Y. β3 integrin is dispensable for conditioned fear and hebbian forms of plasticity in the hippocampus. Eur J Neurosci. 2012;36(4):24612469.CrossRefGoogle ScholarPubMed
Varney, S, Polston, KF, Jessen, T, Carneiro, AM. Mice lacking integrin β3 expression exhibit altered response to chronic stress. Neurobiol Stress. 2015;2:5158.CrossRefGoogle ScholarPubMed
Mirnics, K, Middleton, FA, Lewis, DA, Levitt, P. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci. 2001;24(8):479486.CrossRefGoogle ScholarPubMed
McCullumsmith, RE, Clinton, SM, Meador-Woodruff, JH. Schizophrenia as a disorder of neuroplasticity. Int Rev Neurobiol. 2004;59:1945.CrossRefGoogle ScholarPubMed
Eastwood, SL. The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame? Int Rev Neurobiol. 2004;59:4772.CrossRefGoogle ScholarPubMed
Stephan, KE, Baldeweg, T, Friston, KJ. Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry. 2006;59(10):929939.CrossRefGoogle ScholarPubMed
Pocklington, AJ, O’Donovan, M, and Owen, MJ. The synapse in schizophrenia. Eur J Neurosci. 2014;39(7):10591067.CrossRefGoogle ScholarPubMed
Yin, DM, Chen, YJ, Sathyamurthy, A, Xiong, WC, Mei, L. Synaptic dysfunction in schizophrenia. Adv Exp Med Biol. 2012;970:493516.CrossRefGoogle ScholarPubMed
Moosmang, S, Haider, N, Klugbauer, N, Adelsberger, H, Langwieser, N, Müller, J, Stiess, M, Marais, E, Schulla, V, Lacinova, L, Goebbels, S, Nave, KA, Storm, DR, Hofmann, F, Kleppisch, T. Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. J Neurosci. 2005;25(43):98839892.CrossRefGoogle ScholarPubMed
Nikonenko, I, Toni, N, Moosmayer, M, Shigeri, Y, Muller, D, Sargent Jones, L. Integrins are involved in synaptogenesis, cell spreading, and adhesion in the postnatal brain. Brain Res Dev Brain Res. 2003;140(2):185194.CrossRefGoogle ScholarPubMed
Mortillo, S, Elste, A, Ge, Y, Patil, SB, Hsiao, K, Huntley, GW, Davis, RL, Benson, DL. Compensatory redistribution of neuroligins and N-cadherin following deletion of synaptic β1-integrin. J Comp Neurol, 2012;520(9):20412052.CrossRefGoogle ScholarPubMed
Kerrisk, ME, Greer, CA, Koleske, AJ. Integrin α3 is required for late postnatal stability of dendrite arbors, dendritic spines and synapses, and mouse behavior. J Neurosci. 2013;33(16):67426752.CrossRefGoogle ScholarPubMed
Warren, MS, Bradley, WD, Gourley, SL, Lin, YC, Simpson, MA, Reichardt, LF, Greer, CA, Taylor, JR, Koleske, AJ. Integrin β1 signals through Arg to regulate postnatal dendritic arborization, synapse density, and behavior. J Neurosci. 2012;32(8):28242834.CrossRefGoogle ScholarPubMed
Chan, CS, Levenson, JM, Mukhopadhyay, PS, Zong, L, Bradley, A, Sweatt, J D, Davis, RL. Alpha3-integrins are required for hippocampal long-term potentiation and working memory. Learn Mem, 2007;14(9):606615.CrossRefGoogle ScholarPubMed
Chan, CS, Weeber, EJ, Zong, L, Fuchs, E, Sweatt, JD, Davis, RL. Beta 1-integrins are required for hippocampal AMPA receptor-dependent synaptic transmission, synaptic plasticity, and working memory. J Neurosci. 2006;26(1):223232.CrossRefGoogle ScholarPubMed
Omar, MH, Kerrisk Campbell, M, Xiao, X, Zhong, Q, Brunken, WJ, Miner, JH, Greer, CA, Koleske, AJ. CNS neurons deposit laminin α5 to stabilize synapses. Cell Rep. 2017;21(5):12811292.CrossRefGoogle ScholarPubMed
Lin, YC, Yeckel, MF, Koleske, AJ. Abl2/Arg controls dendritic spine and dendrite arbor stability via distinct cytoskeletal control pathways. J Neurosci. 2013;33(5):18461857.CrossRefGoogle ScholarPubMed
Sfakianos, MK, Eisman, A, Gourley, SL, Bradley, WD, Scheetz, AJ, Settleman, J, Taylor, JR, Greer, CA, Williamson, A, Koleske, AJ. Inhibition of Rho via Arg and p190RhoGAP in the postnatal mouse hippocampus regulates dendritic spine maturation, synapse and dendrite stability, and behavior. J Neurosci. 2007;27(41):1098210992.CrossRefGoogle ScholarPubMed
Simpson, MA, Bradley, WD, Harburger, D, Parsons, M, Calderwood, DA, Koleske, AJ. Direct interactions with the integrin β1 cytoplasmic tail activate the Abl2/Arg kinase. J Biol Chem. 2015;290(13):83608372.CrossRefGoogle ScholarPubMed
Cingolani, LA, Goda, Y. Differential involvement of beta3 integrin in pre- and postsynaptic forms of adaptation to chronic activity deprivation. Neuron Glia Biol. 2008;4(3):179187.CrossRefGoogle ScholarPubMed
Pozo, K, Cingolani, LA, Bassani, S, Laurent, F, Passafaro, M, Goda, Y. β3 integrin interacts directly with GluA2 AMPA receptor subunit and regulates AMPA receptor expression in hippocampal neurons. Proc Natl Acad Sci U S A. 2012;109(4):13231328.CrossRefGoogle ScholarPubMed
Lin, CY, Hilgenberg, LG, Smith, MA, Lynch, G, Gall, CM. Integrin regulation of cytoplasmic calcium in excitatory neurons depends upon glutamate receptors and release from intracellular stores. Mol Cell Neurosci. 2008;37(4):770780.CrossRefGoogle ScholarPubMed
Liu, X, Huai, J, Endle, H, Schlüter, L, Fan, W, Li, Y, Richers, S, Yurugi, H, Rajalingam, K, Ji, H, Cheng, H, Rister, B, Horta, G, Baumgart, J, Berger, H, Laube, G, Schmitt, U, Schmeisser, MJ, Boeckers, TM, Tenzer, S, Vlachos, A, Deller, T, Nitsch, R, Vogt, J. PRG-1 regulates synaptic plasticity via intracellular PP2A/β1-integrin signaling. Dev Cell. 2016;38(3):275290.CrossRefGoogle ScholarPubMed
Huang, Z, Shimazu, K, Woo, NH, Zang, K, Müller, U, Lu, B, Reichardt, LF. Distinct roles of the beta 1-class integrins at the developing and the mature hippocampal excitatory synapse. J Neurosci. 2006;26(43):1120811219.CrossRefGoogle ScholarPubMed
Wang, W, Jia, Y, Pham, DT, Palmer, LC, Jung, KM, Cox, CD, Rumbaugh, G, Piomelli, D, Gall, CM, Lynch, G. Atypical endocannabinoid signaling initiates a new form of memory-related plasticity at a cortical input to hippocampus. Cereb Cortex. 2018;28(7):22532266.CrossRefGoogle Scholar
Kawaguchi, SY, Hirano, T. Integrin alpha3beta1 suppresses long-term potentiation at inhibitory synapses on the cerebellar Purkinje neuron. Mol Cell Neurosci. 2006;31(3):416426.CrossRefGoogle ScholarPubMed
Park, YK, Goda, Y. Integrins in synapse regulation. Nat Rev Neurosci. 2016;17(12):745756.CrossRefGoogle ScholarPubMed
Chen, YJ, Zhang, M, Yin, DM, Wen, L, Ting, A, Wang, P, Lu, YS, Zhu, XH, Li, SJ, Wu, CY, Wang, XM, Lai, C, Xiong, WC, Mei, L, Gao, TM. ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation. Proc Natl Acad Sci U S A. 2010;107(50):2181821823.CrossRefGoogle ScholarPubMed
Huang, YZ, Won, S, Ali, DW, Wang, Q, Tanowitz, M, Du, QS, Pelkey, KA, Yang, DJ, Xiong, WC, Salter, MW, Mei, L. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron. 2000;26(2):443455.CrossRefGoogle ScholarPubMed
Woo, RS, Li, XM, Tao, Y, Carpenter-Hyland, E, Huang, YZ, Weber, J, Neiswender, H, Dong, XP, Wu, J, Gassmann, M, Lai, C, Xiong, WC, Gao, TM, Mei, L. Neuregulin-1 enhances depolarization-induced GABA release. Neuron. 2007;54(4):599610.CrossRefGoogle ScholarPubMed
Wen, L, Lu, YS, Zhu, XH, Li, XM, Woo, RS, Chen, YJ, Yin, DM, Lai, C, Terry, AV Jr., Vazdarjanova, A, Xiong, WC, Mei, L. Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc Natl Acad Sci U S A. 2010;107(3):12111216.CrossRefGoogle ScholarPubMed
Bogerts, B, Meertz, E, Schönfeldt-Bausch, R. Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch Gen Psychiatry. 1985;42(8):784791.CrossRefGoogle ScholarPubMed
Brown, R, Colter, N, Corsellis, JA, Crow, TJ, Frith, CD, Jagoe, R, Johnstone, EC, Marsh, L. Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry. 1986;43(1):3642.CrossRefGoogle ScholarPubMed
Pakkenberg, B. Post-mortem study of chronic schizophrenic brains. Br J Psychiatry. 1987;151:744752.CrossRefGoogle ScholarPubMed
Wong, AH, Van Tol, HH. Schizophrenia: from phenomenology to neurobiology. Neurosci Biobehav Rev. 2003;27(3):269306.CrossRefGoogle ScholarPubMed
Haijma, SV, Van Haren, N, Cahn, W, Koolschijn, PC, Hulshoff Pol, HE, Kahn, RS. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr Bull. 2013;39(5):11291138.CrossRefGoogle ScholarPubMed
Blaess, S, Graus-Porta, D, Belvindrah, R, Radakovits, R, Pons, S, Littlewood-Evans, A, Senften, M, Guo, H, Li, Y, Miner, JH, Reichardt, LF, Müller, U. Beta1-integrins are critical for cerebellar granule cell precursor proliferation. J Neurosci. 2004;24(13):34023412.CrossRefGoogle ScholarPubMed
Ellegood, J, Henkelman, RM, Lerch, JP. Neuroanatomical assessment of the integrin β3 mouse model related to autism and the serotonin system using high resolution MRI. Front Psychiatry. 2012;3:37.CrossRefGoogle ScholarPubMed
Steadman, PE, Ellegood, J, Szulc, KU, Turnbull, DH, Joyner, AL, Henkelman, RM, Lerch, JP. Genetic effects on cerebellar structure across mouse models of autism using a magnetic resonance imaging atlas. Autism Res. 2014;7(1):124137.CrossRefGoogle ScholarPubMed
Xie, T, Zhang, X, Tang, X, Zhang, H, Yu, M, Gong, G, Wang, X, Evans, A, Zhang, Z, He, Y. Mapping convergent and divergent cortical thinning patterns in patients with deficit and nondeficit schizophrenia. Schizophr Bull. 2019;45(1):211221.CrossRefGoogle ScholarPubMed
Planchuelo-Gómez, Á, Lubeiro, A, Núñez-Novo, P, Gomez-Pilar, J, de Luis-García, R, Del Valle, P, Martín-Santiago, Ó, Pérez-Escudero, A, Molina, V. Identificacion of MRI-based psychosis subtypes: Replication and refinement. Prog Neuropsychopharmacol Biol Psychiatry. 2020;100:109907.CrossRefGoogle ScholarPubMed
Schmid, RS, Anton, ES. Role of integrins in the development of the cerebral cortex. Cereb Cortex. 2003;13(3):219224.CrossRefGoogle ScholarPubMed
Cousin, B, Leloup, C, Pénicaud, L, Price, J. Developmental changes in integrin beta-subunits in rat cerebral cortex. Neurosci Lett. 1997;234(2-3):161165.CrossRefGoogle ScholarPubMed
Pinkstaff, JK, Detterich, J, Lynch, G, Gall, C. Integrin subunit gene expression is regionally differentiated in adult brain. J Neurosci. 1999; 19(5):15411556.CrossRefGoogle ScholarPubMed
Nishimura, SL, Boylen, KP, Einheber, S, Milner, TA, Ramos, DM, Pytela, R. Synaptic and glial localization of the integrin alphavbeta8 in mouse and rat brain. Brain Res. 1998;791(1-2):271282.CrossRefGoogle ScholarPubMed
Graus-Porta, D, Blaess, S, Senften, M, Littlewood-Evans, A, Damsky, C, Huang, Z, Orban, P, Klein, R, Schittny, JC, Müller, U. Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron. 2001;31(3):367379.CrossRefGoogle ScholarPubMed
Milner, R, Campbell, IL. The integrin family of cell adhesion molecules has multiple functions within the CNS. J Neurosci Res. 2002;69(3):286291.CrossRefGoogle ScholarPubMed
Mercado, ML, Nur-e-Kamal, A, Liu, HY, Gross, SR, Movahed, R, Meiners, S. Neurite outgrowth by the alternatively spliced region of human tenascin-C is mediated by neuronal alpha7beta1 integrin. J Neurosci. 2004;24(1):238247.CrossRefGoogle ScholarPubMed
Shi, Y, Ethell, IM. Integrins control dendritic spine plasticity in hippocampal neurons through NMDA receptor and Ca2+/calmodulin-dependent protein kinase II-mediated actin reorganization. J Neurosci. 2006;26(6):18131822.CrossRefGoogle ScholarPubMed
Ning, L, Tian, L, Smirnov, S, Vihinen, H, Llano, O, Vick, K, Davis, RL, Rivera, C, Gahmberg, CG. Interactions between ICAM-5 and β1 integrins regulate neuronal synapse formation. J Cell Sci. 2013;126(Pt 1):7789.CrossRefGoogle ScholarPubMed
Swinehart, BD, Bland, KM, Holley, ZL, Lopuch, AJ, Casey, ZO, Handwerk, CJ, Vidal, GS. Integrin β3 organizes dendritic complexity of cerebral cortical pyramidal neurons along a tangential gradient. Mol Brain. 2020;13(1):168.CrossRefGoogle ScholarPubMed
Song, G, Luo, BH. Atypical structure and function of integrin α(V) β(8). J Cell Physiol. 2021;236(7):48744887.CrossRefGoogle Scholar
Luo, BH, Carman, CV, Springer, TA. Structural basis of integrin regulation and signaling. Annu Rev Immunol. 2007;25:619647.CrossRefGoogle ScholarPubMed
Yonekawa, K, Harlan, JM. Targeting leukocyte integrins in human diseases. J Leukoc Biol. 2005;77(2):129140.CrossRefGoogle ScholarPubMed
Altorki, T, Muller, W, Brass, A, Cruickshank, S. The role of β(2) integrin in dendritic cell migration during infection. BMC Immunol. 2021;22(1):2.CrossRefGoogle ScholarPubMed
Li, D, Peng, J, Li, T, Liu, Y, Chen, M, Shi, X. Itgb3-integrin-deficient mice may not be a sufficient model for patients with Glanzmann thrombasthenia. Mol Med Rep. 2021;23(6):449.CrossRefGoogle Scholar
Murgia, C, Blaikie, P, Kim, N, Dans, M, Petrie, HT, Giancotti, FG. Cell cycle and adhesion defects in mice carrying a targeted deletion of the integrin beta4 cytoplasmic domain. EMBO J. 1998;17(14):39403951.CrossRefGoogle ScholarPubMed
Colburn, ZT, Jones, JC. α(6)β(4) integrin regulates the collective migration of epithelial cells. Am J Respir Cell Mol Biol. 2017;56(4):443452.CrossRefGoogle Scholar
Nandrot, EF, Anand, M, Sircar, M, Finnemann, SC. Novel role for alphavbeta5-integrin in retinal adhesion and its diurnal peak. Am J Physiol Cell Physiol. 2006;290(4):C1256C1262.CrossRefGoogle ScholarPubMed
Nandrot, EF, Kim, Y, Brodie, SE, Huang, X, Sheppard, D, Finnemann, SC. Loss of synchronized retinal phagocytosis and age-related blindness in mice lacking alphavbeta5 integrin. J Exp Med. 2004;200(12):15391545.CrossRefGoogle ScholarPubMed
Xie, Y, McElwee, KJ, Owen, GR, Häkkinen, L, Larjava, HS. Integrin β6-deficient mice show enhanced keratinocyte proliferation and retarded hair follicle regression after depilation. J Invest Dermatol, 2012;132(3 Pt 1):547555.CrossRefGoogle ScholarPubMed
Hogmalm, A, Sheppard, D, Lappalainen, U, Bry, K. beta6 Integrin subunit deficiency alleviates lung injury in a mouse model of bronchopulmonary dysplasia. Am J Respir Cell Mol Biol. 2010;43(1):8898.CrossRefGoogle Scholar
Artis, D, Humphreys, NE, Potten, CS, Wagner, N, Müller, W, McDermott, JR, Grencis, RK, Else, KJ. Beta7 integrin-deficient mice: delayed leukocyte recruitment and attenuated protective immunity in the small intestine during enteric helminth infection. Eur J Immunol. 2000;30(6):16561664.3.0.CO;2-Z>CrossRefGoogle ScholarPubMed
Kaemmerer, E, Kuhn, P, Schneider, U, Clahsen, T, Jeon, MK, Klaus, C, Andruszkow, J, Härer, M, Ernst, S, Schippers, A, Wagner, N, Gassler, N. Beta-7 integrin controls enterocyte migration in the small intestine. World J Gastroenterol. 2015;21(6):17591764.CrossRefGoogle ScholarPubMed
Proctor, JM, Zang, K, Wang, D, Wang, R, Reichardt, LF. Vascular development of the brain requires beta8 integrin expression in the neuroepithelium. J Neurosci. 2005;25(43):99409948.CrossRefGoogle ScholarPubMed
Berk, M, Plein, H, Csizmadia, T. Supersensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia. Int Clin Psychopharmacol. 1999;14(2):119122.CrossRefGoogle ScholarPubMed
Kim, JS, Kornhuber, HH, Schmid-Burgk, W, Holzmüller, B. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett. 1980;20(3):379382.CrossRefGoogle Scholar
Tsai, G, Passani, LA, Slusher, BS, Carter, R, Baer, L, Kleinman, JE, Coyle, JT. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry. 1995;52(10):829836.CrossRefGoogle ScholarPubMed
Howes, OD, Kapur, S. The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull. 2009;35(3):549562.CrossRefGoogle ScholarPubMed
Javitt, DC, Spencer, KM, Thaker, GK, Winterer, G, Hajós, M. Neurophysiological biomarkers for drug development in schizophrenia. Nat Rev Drug Discov. 2008;7(1):6883.CrossRefGoogle ScholarPubMed
Brennand, KJ, Simone, A, Jou, J, Gelboin-Burkhart, C, Tran, N, Sangar, S, Li, Y, Mu, Y, Chen, G, Yu, D, McCarthy, S, Sebat, J, Gage, FH. Modelling schizophrenia using human induced pluripotent stem cells. Nature. 2011;473(7346):221225.CrossRefGoogle ScholarPubMed
Zamanpoor, M. Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights. Psychiatr Genet. 2020;30(1):19.CrossRefGoogle Scholar
Balu, DT. The NMDA receptor and schizophrenia: from pathophysiology to treatment. Adv Pharmacol. 2016;76:351382.CrossRefGoogle ScholarPubMed
Vinson, PN, Conn, PJ. Metabotropic glutamate receptors as therapeutic targets for schizophrenia. Neuropharmacology. 2012;62(3):14611472.CrossRefGoogle ScholarPubMed
Nicoletti, F, Orlando, R, Di Menna, L, Cannella, M, Notartomaso, S, Mascio, G, Iacovelli, L, Matrisciano, F, Fazio, F, Caraci, F, Copani, A, Battaglia, G, Bruno, V. Targeting mGlu receptors for optimization of antipsychotic activity and disease-modifying effect in schizophrenia. Front Psychiatry. 2019;10:49.CrossRefGoogle ScholarPubMed
Dogra, S, Conn, PJ. Metabotropic glutamate receptors as emerging targets for the treatment of schizophrenia. Mol Pharmacol. 2022;101(5):275285.CrossRefGoogle ScholarPubMed
Jaudon, F, Thalhammer, A, Zentilin, L, Cingolani, LA. CRISPR-mediated activation of autism gene Itgb3 restores cortical network excitability via mGluR5 signaling. Mol Ther Nucleic Acids. 2022;29:462480.CrossRefGoogle ScholarPubMed
Clegg, DO, Wingerd, KL, Hikita, ST, Tolhurst, EC. Integrins in the development, function and dysfunction of the nervous system. Front Biosci. 2003;8:d723d750.CrossRefGoogle ScholarPubMed
Mohn, AR, Gainetdinov, RR, Caron, MG, Koller, BH. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell. 1999;98(4):427436.CrossRefGoogle ScholarPubMed
Lin, B, Arai, AC, Lynch, G, Gall, CM. Integrins regulate NMDA receptor-mediated synaptic currents. J Neurophysiol. 2003;89(5):28742878.CrossRefGoogle ScholarPubMed
Bernard-Trifilo, JA, Kramár, EA, Torp, R, Lin, CY, Pineda, EA, Lynch, G, Gall, CM. Integrin signaling cascades are operational in adult hippocampal synapses and modulate NMDA receptor physiology. J Neurochem. 2005;93(4):834849.CrossRefGoogle ScholarPubMed
Jaudon, F, Thalhammer, A, Cingolani, LA. Integrin adhesion in brain assembly: from molecular structure to neuropsychiatric disorders. Eur J Neurosci. 2021;53(12):38313850.CrossRefGoogle ScholarPubMed
Groc, L, Choquet, D, Stephenson, FA, Verrier, D, Manzoni, OJ, Chavis, P. NMDA receptor surface trafficking and synaptic subunit composition are developmentally regulated by the extracellular matrix protein Reelin. J Neurosci. 2007;27(38):1016510175.CrossRefGoogle ScholarPubMed
Iafrati, J, Orejarena, MJ, Lassalle, O, Bouamrane, L, Gonzalez-Campo, C, Chavis, P. Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway. Mol Psychiatry. 2014;19(4):417426.CrossRefGoogle ScholarPubMed
Lin, CY, Lynch, G, Gall, CM. AMPA receptor stimulation increases alpha5beta1 integrin surface expression, adhesive function and signaling. J Neurochem. 2005;94(2):531546.CrossRefGoogle ScholarPubMed
Cingolani, LA, Thalhammer, A, Yu, LM, Catalano, M, Ramos, T, Colicos, MA, Goda, Y. Activity-dependent regulation of synaptic AMPA receptor composition and abundance by beta3 integrins. Neuron. 2008;58(5):749762.CrossRefGoogle ScholarPubMed
Fossati, G, Pozzi, D, Canzi, A, Mirabella, F, Valentino, S, Morini, R, Ghirardini, E, Filipello, F, Moretti, M, Gotti, C, Annis, DS, Mosher, DF, Garlanda, C, Bottazzi, B, Taraboletti, G, Mantovani, A, Matteoli, M, Menna, E. Pentraxin 3 regulates synaptic function by inducing AMPA receptor clustering via ECM remodeling and β1-integrin. EMBO J. 2019;38(1):e99529.CrossRefGoogle ScholarPubMed
Birkner, K, Wasser, B, Ruck, T, Thalman, C, Luchtman, D, Pape, K, Schmaul, S, Bitar, L, Krämer-Albers, EM, Stroh, A, Meuth, SG, Zipp, F, Bittner, S. β1-Integrin- and KV1.3 channel-dependent signaling stimulates glutamate release from Th17 cells. J Clin Invest. 2020;130(2):715732.CrossRefGoogle ScholarPubMed
Weiss, LA, Veenstra-Vanderweele, J, Newman, DL, Kim, SJ, Dytch, H, MS, McPeek, Cheng, S, Ober, C, Cook, EH Jr., Abney, M. Genome-wide association study identifies ITGB3 as a QTL for whole blood serotonin. Eur J Hum Genet. 2004;12(11):949954.CrossRefGoogle ScholarPubMed
Weiss, LA, Abney, M, Parry, R, Scanu, AM, Cook, EH Jr., Ober, C. Variation in ITGB3 has sex-specific associations with plasma lipoprotein(a) and whole blood serotonin levels in a population-based sample. Hum Genet. 2005;117(1):8187.CrossRefGoogle Scholar
Weiss, LA, Kosova, G, Delahanty, RJ, Jiang, L, Cook, EH, Ober, C, Sutcliffe, JS. Variation in ITGB3 is associated with whole-blood serotonin level and autism susceptibility. Eur J Hum Genet. 2006;14(8):923931.CrossRefGoogle ScholarPubMed
Napolioni, V, Lombardi, F, Sacco, R, Curatolo, P, Manzi, B, Alessandrelli, R, Militerni, R, Bravaccio, C, Lenti, C, Saccani, M, Schneider, C, Melmed, R, Pascucci, T, Puglisi-Allegra, S, Reichelt, KL, Rousseau, F, Lewin, P, Persico, AM. Family-based association study of ITGB3 in autism spectrum disorder and its endophenotypes. Eur J Hum Genet. 2011;19(3):353359.CrossRefGoogle ScholarPubMed
Coutinho, AM, Sousa, I, Martins, M, Correia, C, Morgadinho, T, Bento, C, Marques, C, Ataíde, A, Miguel, TS, Moore, JH, Oliveira, G, Vicente, AM. Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum Genet. 2007;121(2):243256.CrossRefGoogle ScholarPubMed
Carneiro, AM, Cook, EH, Murphy, DL, Blakely, RD. Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest. 2008;118(4):15441552.CrossRefGoogle ScholarPubMed
Weiss, LA, Ober, C, Cook, EH. ITGB3 shows genetic and expression interaction with SLC6A4. Hum Genet. 2006;120(1):93100.CrossRefGoogle ScholarPubMed
Whyte, A, Jessen, T, Varney, S, Carneiro, AM. Serotonin transporter and integrin beta 3 genes interact to modulate serotonin uptake in mouse brain. Neurochem Int. 2014;73:122126.CrossRefGoogle ScholarPubMed
Mazalouskas, M, Jessen, T, Varney, S, Sutcliffe, JS, Veenstra-Vander Weele, J, Cook, EH Jr., Carneiro, AM. Integrin β3 haploinsufficiency modulates serotonin transport and antidepressant-sensitive behavior in mice. Neuropsychopharmacology. 2015;40(8):20152024.CrossRefGoogle ScholarPubMed
Dohn, MR, Kooker, CG, Bastarache, L, Jessen, T, Rinaldi, C, Varney, S, Mazalouskas, MD, Pan, H, Oliver, KH, Velez Edwards, DR, Sutcliffe, JS, Denny, JC, Carneiro, AMD. The gain-of-function integrin β3 Pro33 variant alters the serotonin system in the mouse brain. J Neurosci. 2017;37(46):1127111284.CrossRefGoogle ScholarPubMed
Gabriele, S, Canali, M, Lintas, C, Sacco, R, Tirindelli, MC, Ricciardello, A, Persico, AM. Evidence that ITGB3 promoter variants increase serotonin blood levels by regulating platelet serotonin transporter trafficking. Hum Mol Genet. 2019;28(7):11531161.CrossRefGoogle ScholarPubMed
Oved, K, Morag, A, Pasmanik-Chor, M, Rehavi, M, Shomron, N, Gurwitz, D. Genome-wide expression profiling of human lymphoblastoid cell lines implicates integrin beta-3 in the mode of action of antidepressants. Transl Psychiatry. 2013;3(10):e313.CrossRefGoogle ScholarPubMed
Turkmen, BA. Yazici, E, Erdogan, DG, Suda, MA, Yazici, AB. BDNF, GDNF, NGF and Klotho levels and neurocognitive functions in acute term of schizophrenia. BMC Psychiatry. 2021;21(1):562.CrossRefGoogle ScholarPubMed
Libman-Sokołowska, M, Drozdowicz, E, Nasierowski, T. BDNF as a biomarker in the course and treatment of schizophrenia. Psychiatr Pol. 2015;49(6):11491158.CrossRefGoogle ScholarPubMed
Chen, DC, Wang, J, Wang, B, Yang, SC, Zhang, CX, Zheng, YL, Li, YL, Wang, N, Yang, KB, Xiu, MH, Kosten, TR, Zhang, XY. Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes. Psychopharmacology (Berl). 2009;207(3):375380.CrossRefGoogle ScholarPubMed
Ikeda, Y, Yahata, N, Ito, I, Nagano, M, Toyota, T, Yoshikawa, T, Okubo, Y, Suzuki, H. Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia. Schizophr Res. 2008;101(1-3):5866.CrossRefGoogle ScholarPubMed
Jindal, RD, Pillai, AK, Mahadik, SP, Eklund, K, Montrose, DM, Keshavan, MS. Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia. Schizophr Res. 2010;119(1-3):4751.CrossRefGoogle ScholarPubMed
Toyooka, K, Asama, K, Watanabe, Y, Muratake, T, Takahashi, M, Someya, T, Nawa, H. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res. 2002;110(3):249257.CrossRefGoogle ScholarPubMed
Vinogradov, S, Fisher, M, Holland, C, Shelly, W, Wolkowitz, O, Mellon, SH. Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia? Biol Psychiatry. 2009;66(6):549553.CrossRefGoogle ScholarPubMed
Gama, CS, Andreazza, AC, Kunz, M, Berk, M, Belmonte-de-Abreu, PS, Kapczinski, F. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neurosci Lett. 2007;420(1):4548.CrossRefGoogle ScholarPubMed
Reis, HJ, Nicolato, R, Barbosa, IG, Teixeira do Prado, PH, Romano-Silva, MA, Teixeira, AL. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neurosci Lett. 2008;439(2):157159.CrossRefGoogle ScholarPubMed
Favalli, G, Li, J, Belmonte-de-Abreu, P, Wong, AH, Daskalakis, ZJ. The role of BDNF in the pathophysiology and treatment of schizophrenia. J Psychiatr Res. 2012;46(1):111.CrossRefGoogle ScholarPubMed
Pandya, CD, Kutiyanawalla, A, Pillai, A. BDNF-TrkB signaling and neuroprotection in schizophrenia. Asian J Psychiatr. 2013;6(1):2228.CrossRefGoogle ScholarPubMed
Peng, S, Li, W, Lv, L, Zhang, Z, Zhan, X. BDNF as a biomarker in diagnosis and evaluation of treatment for schizophrenia and depression. Discov Med. 2018;26(143):127136.Google ScholarPubMed
Singh, J, Verma, R, Raghav, R, Sarkar, S, Sood, M, Jain, R. Brain-derived neurotrophic factor (BDNF) levels in first-episode schizophrenia and healthy controls: A comparative study. Asian J Psychiatr. 2020;54:102370.CrossRefGoogle ScholarPubMed
Li, S, Chen, D, Xiu, M, Li, J, Zhang, XY. Diabetes mellitus, cognitive deficits and serum BDNF levels in chronic patients with schizophrenia: A case-control study. J Psychiatr Res. 2021;134:3947.CrossRefGoogle ScholarPubMed
Hori, H, Yoshimura, R, Katsuki, A, Atake, K, Igata, R, Konishi, Y, Nakamura, J. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy. World J Biol Psychiatry. 2017;18(5):401408.CrossRefGoogle ScholarPubMed
Yang, Y, Liu, Y, Wang, G, Hei, G, Wang, X, Li, R, Li, L, Wu, R, Zhao, J. Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia. Psychiatry Res. 2019;273:528536.CrossRefGoogle ScholarPubMed
Gall, CM, Pinkstaff, JK, Lauterborn, JC, Xie, Y, Lynch, G. Integrins regulate neuronal neurotrophin gene expression through effects on voltage-sensitive calcium channels. Neuroscience. 2003;118(4):925940.CrossRefGoogle ScholarPubMed
Murase, S, Owens, DF, McKay, RD. In the newborn hippocampus, neurotrophin-dependent survival requires spontaneous activity and integrin signaling. J Neurosci. 2011;31(21):77917800.CrossRefGoogle ScholarPubMed
Cao, JP, Yu, JK, Li, C, Sun, Y, Yuan, HH, Wang, HJ, Gao, DS. Integrin beta1 is involved in the signaling of glial cell line-derived neurotrophic factor. J Comp Neurol. 2008;509(2):203210.CrossRefGoogle ScholarPubMed
Yokomaku, D, Numakawa, T, Numakawa, Y, Suzuki, S, Matsumoto, T, Adachi, N, Nishio, C, Taguchi, T, Hatanaka, H. Estrogen enhances depolarization-induced glutamate release through activation of phosphatidylinositol 3-kinase and mitogen-activated protein kinase in cultured hippocampal neurons. Mol Endocrinol. 2003;17(5):831844.CrossRefGoogle ScholarPubMed
Smejkalova, T, Woolley, CS. Estradiol acutely potentiates hippocampal excitatory synaptic transmission through a presynaptic mechanism. J Neurosci. 2010;30(48):1613716148.CrossRefGoogle ScholarPubMed
Oberlander, JG, Woolley, CS. 17β-estradiol acutely potentiates glutamatergic synaptic transmission in the hippocampus through distinct mechanisms in males and females. J Neurosci. 2016;36(9):26772690.CrossRefGoogle ScholarPubMed
Wang, W, Kantorovich, S, Babayan, AH, Hou, B, Gall, CM, Lynch, G. Estrogen’s effects on excitatory synaptic transmission entail integrin and TrkB transactivation and depend upon β1-integrin function. Neuropsychopharmacology. 2016;41(11):27232732.CrossRefGoogle ScholarPubMed
Nishimura, K, Doi, D, Samata, B, Murayama, S, Tahara, T, Onoe, H, Takahashi, J. Estradiol facilitates functional integration of iPSC-derived dopaminergic neurons into striatal neuronal circuits via activation of integrin α5β1. Stem Cell Rep. 2016;6(4):511524.CrossRefGoogle ScholarPubMed
Rune, GM, Frotscher, M. Neurosteroid synthesis in the hippocampus: role in synaptic plasticity. Neuroscience. 2005;136(3):833842.CrossRefGoogle ScholarPubMed
Liu, F, Day, M, Muñiz, LC, Bitran, D, Arias, R, Revilla-Sanchez, R, Grauer, S, Zhang, G, Kelley, C, Pulito, V, Sung, A, Mervis, RF, Navarra, R, Hirst, WD, Reinhart, PH, Marquis, KL, Moss, SJ, Pangalos, MN, Brandon, NJ. Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci. 2008;11(3):334343.CrossRefGoogle ScholarPubMed
Spencer-Segal, JL, Tsuda, MC, Mattei, L, Waters, EM, Romeo, RD, Milner, TA, BS, McEwen, Ogawa, S. Estradiol acts via estrogen receptors alpha and beta on pathways important for synaptic plasticity in the mouse hippocampal formation. Neuroscience. 2012;202:131146.CrossRefGoogle ScholarPubMed
Lu, Y, Sareddy, GR, Wang, J, Wang, R, Li, Y, Dong, Y, Zhang, Q, Liu, J, O’Connor, JC, Xu, J, Vadlamudi, RK, Brann, DW. Neuron-Derived estrogen regulates synaptic plasticity and memory. J Neurosci. 2019;39(15):27922809.CrossRefGoogle ScholarPubMed
Clements, L, Harvey, J. Activation of oestrogen receptor α induces a novel form of LTP at hippocampal temporoammonic-CA1 synapses. Br J Pharmacol. 2020;177(3):642655.CrossRefGoogle ScholarPubMed
Belcher, SM, Zsarnovszky, A. Estrogenic actions in the brain: estrogen, phytoestrogens, and rapid intracellular signaling mechanisms. J Pharmacol Exp Ther. 2001;299(2):408414.Google ScholarPubMed
Huang, X, Zhu, LL, Zhao, T, Wu, LY, Wu, KW, Schachner, M, Xiao, ZC, Fan, M. CHL1 negatively regulates the proliferation and neuronal differentiation of neural progenitor cells through activation of the ERK1/2 MAPK pathway. Mol Cell Neurosci. 2011;46(1):296307.CrossRefGoogle ScholarPubMed
Schmid, RS, Maness, PF. L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth. Curr Opin Neurobiol. 2008;18(3):245250.CrossRefGoogle ScholarPubMed
Chen, S, Mantei, N, Dong, L, Schachner, M. Prevention of neuronal cell death by neural adhesion molecules L1 and CHL1. J Neurobiol. 1999;38(3):428439.3.0.CO;2-6>CrossRefGoogle ScholarPubMed
Braus, DF. Temporal perception and organisation, neuronal synchronisation and schizophrenia. Fortschr Neurol Psychiatr. 2002;70(11):591600.CrossRefGoogle ScholarPubMed
Kimura, B. Disturbance of timing and selfhood in schizophrenia. Seishin Shinkeigaku Zasshi. 2003;105(6):729732.Google ScholarPubMed
Penney, TB, Meck, WH, Roberts, SA, Gibbon, J, Erlenmeyer-Kimling, L. Interval-timing deficits in individuals at high risk for schizophrenia. Brain Cogn. 2005;58(1):109118.CrossRefGoogle ScholarPubMed
Volz, HP, Nenadic, I, Gaser, C, Rammsayer, T, Häger, F, Sauer, H. Time estimation in schizophrenia: an fMRI study at adjusted levels of difficulty. Neuroreport. 2001;12(2):313316.CrossRefGoogle ScholarPubMed
Herzog, MH, Brand, A. Pitting temporal against spatial integration in schizophrenic patients. Psychiatry Res. 2009;168(1):110.CrossRefGoogle ScholarPubMed
Velasques, B, Machado, S, Paes, F, Cunha, M, Sanfim, A, Budde, H, Cagy, M, Anghinah, R, Basile, LF, Piedade, R, Ribeiro, P. Sensorimotor integration and psychopathology: motor control abnormalities related to psychiatric disorders. World J Biol Psychiatry. 2011;12(8):560573.CrossRefGoogle ScholarPubMed
Buhusi, M, Scripa, I, Williams, CL, Buhusi, CV. Impaired interval timing and spatial-temporal integration in mice deficient in CHL1, a gene associated with schizophrenia. Timing Time Percept. 2013;1(1):2138.CrossRefGoogle ScholarPubMed
Shaltout, TE, Alali, KA, Bushra, S, Alkaseri, AM, Jose, ED, Al-Khainji, M, Saleh, R, Salama Dahir, A, Shaltout, H, Al-Abdullah, M, Rizk, NM. Significant association of close homologue of L1 gene polymorphism rs2272522 with schizophrenia in Qatar. Asia Pac Psychiatry. 2013;5(1):1723.CrossRefGoogle ScholarPubMed
Buhusi, M, Obray, D, Guercio, B, Bartlett, MJ, Buhusi, CV. Chronic mild stress impairs latent inhibition and induces region-specific neural activation in CHL1-deficient mice, a mouse model of schizophrenia. Behav Brain Res. 2017;333:18.CrossRefGoogle ScholarPubMed
Ren, J, Zhao, T, Xu, Y, Ye, H. Interaction between DISC1 and CHL1 in regulation of neurite outgrowth. Brain Res. 2016;1648(Pt A):290297.CrossRefGoogle ScholarPubMed
Buhusi, M, Midkiff, BR, Gates, AM, Richter, M, Schachner, M, Maness, PF. Close homolog of L1 is an enhancer of integrin-mediated cell migration. J Biol Chem. 2003;278(27):2502425031.CrossRefGoogle ScholarPubMed
Probst-Schendzielorz, K, Scholl, C, Efimkina, O, Ersfeld, E, Viviani, R, Serretti, A, Fabbri, C, Gurwitz, D, Lucae, S, Ising, M, Paul, AM, Lehmann, ML, Steffens, M, Crisafulli, C, Calabrò, M, Holsboer, F, Stingl, J. CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study. Pharmacogenomics. 2015;16(7):689701.CrossRefGoogle ScholarPubMed
Impagnatiello, F, Guidotti, AR, Pesold, C, Dwivedi, Y, Caruncho, H, Pisu, MG, Uzunov, DP, Smalheiser, NR, Davis, JM, Pandey, GN, Pappas, GD, Tueting, P, Sharma, RP, Costa, E. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci U S A. 1998;95(26):1571815723.CrossRefGoogle ScholarPubMed
Fatemi, SH, Earle, JA, McMenomy, T. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry. 2000;5(6):654–63, 571.CrossRefGoogle ScholarPubMed
Guidotti, A, Auta, J, Davis, JM, Di-Giorgi-Gerevini, V, Dwivedi, Y, Grayson, DR, Impagnatiello, F, Pandey, G, Pesold, C, Sharma, R, Uzunov, D, Costa, E. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry. 2000;57(11):10611069.CrossRefGoogle ScholarPubMed
Guidotti, A, Grayson, DR, Caruncho, HJ. Epigenetic RELN dysfunction in schizophrenia and related neuropsychiatric disorders. Front Cell Neurosci. 2016;10:89.CrossRefGoogle ScholarPubMed
Berretta, S. Extracellular matrix abnormalities in schizophrenia. Neuropharmacology. 2012;62(3):15841597.CrossRefGoogle ScholarPubMed
Sethi, MK, Zaia, J. Extracellular matrix proteomics in schizophrenia and Alzheimer’s disease. Anal Bioanal Chem. 2017;409(2):379394.CrossRefGoogle ScholarPubMed
Lubbers, BR, Smit, AB, Spijker, S, van den Oever, MC. Neural ECM in addiction, schizophrenia, and mood disorder. Prog Brain Res. 2014;214:263284.CrossRefGoogle ScholarPubMed
Sekine, K, Kawauchi, T, Kubo, K, Honda, T, Herz, J, Hattori, M, Kinashi, T, Nakajima, K. Reelin controls neuronal positioning by promoting cell-matrix adhesion via inside-out activation of integrin α5β1. Neuron. 2012;76(2):353369.CrossRefGoogle ScholarPubMed
Dulabon, L, Olson, EC, Taglienti, MG, Eisenhuth, S, McGrath, B, Walsh, CA, Kreidberg, JA, Anton, ES. Reelin binds alpha3beta1 integrin and inhibits neuronal migration. Neuron. 2000;27(1):3344.CrossRefGoogle ScholarPubMed
Hoe, HS, Lee, KJ, Carney, RS, Lee, J, Markova, A, Lee, JY, Howell, BW, Hyman, BT, Pak, DT, Bu, G, Rebeck, GW. Interaction of reelin with amyloid precursor protein promotes neurite outgrowth. J Neurosci. 2009;29(23):74597473.CrossRefGoogle ScholarPubMed
Folsom, TD, Fatemi, SH. The involvement of Reelin in neurodevelopmental disorders. Neuropharmacology. 2013;68:122135.CrossRefGoogle ScholarPubMed
Nagy, V, Bozdagi, O, Matynia, A, Balcerzyk, M, Okulski, P, Dzwonek, J, Costa, RM, Silva, AJ, Kaczmarek, L, Huntley, GW. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J Neurosci. 2006;26(7):19231934.CrossRefGoogle ScholarPubMed
Bozdagi, O, Nagy, V, Kwei, KT, Huntley, GW. In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity. J Neurophysiol. 2007;98(1):334344.CrossRefGoogle ScholarPubMed
Okulski, P, Jay, TM, Jaworski, J, Duniec, K, Dzwonek, J, Konopacki, FA, Wilczynski, GM, Sánchez-Capelo, A, Mallet, J, Kaczmarek, L. TIMP-1 abolishes MMP-9-dependent long-lasting long-term potentiation in the prefrontal cortex. Biol Psychiatry. 2007;62(4):359362.CrossRefGoogle ScholarPubMed
Egan, MF, Weinberger, DR. Neurobiology of schizophrenia. Curr Opin Neurobiol. 1997;7(5):701707.CrossRefGoogle ScholarPubMed
Kalia, M. Neurobiological basis of depression: an update. Metabolism. 2005;54(5 Suppl 1):2427.CrossRefGoogle ScholarPubMed
Bruno, MA, Mufson, EJ, Wuu, J, Cuello, AC. Increased matrix metalloproteinase 9 activity in mild cognitive impairment. J Neuropathol Exp Neurol. 2009;68(12):13091318.CrossRefGoogle ScholarPubMed
Rybakowski, JK. Matrix metalloproteinase-9 (MMP9)-a mediating enzyme in cardiovascular disease, cancer, and neuropsychiatric disorders. Cardiovasc Psychiatry Neurol. 2009;2009:904836.CrossRefGoogle ScholarPubMed
Rybakowski, JK, Skibinska, M, Kapelski, P, Kaczmarek, L, Hauser, J. Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia. Schizophr Res. 2009;109(1-3):9093.CrossRefGoogle ScholarPubMed
Wang, XB, Bozdagi, O, Nikitczuk, JS, Zhai, ZW, Zhou, Q, Huntley, GW. Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately. Proc Natl Acad Sci U S A. 2008;105(49):1952019525.CrossRefGoogle ScholarPubMed
Michaluk, P, Mikasova, L, Groc, L, Frischknecht, R, Choquet, D, Kaczmarek, L. Matrix metalloproteinase-9 controls NMDA receptor surface diffusion through integrin beta1 signaling. J Neurosci. 2009;29(18):60076012.CrossRefGoogle ScholarPubMed
Figure 0

Figure 1. The association among integrin β, schizophrenia, and synapses.Talin and Kindlin act as integrin activators, binding to the cytoplasmic tail of the integrin β subunits thereby activating integrins. LTP is a form of synaptic plasticity, and LTP induction mechanisms require synaptic NMDAR activation and Ca2+ influx to participate in downstream signaling cascades, whereas β1 integrin deficiency impairs LTP; therefore, it can be assumed that β1 integrin has a key role in NMDAR-dependent LTP-induced downstream signaling pathways.36 PRG-1 affects synaptic plasticity in a cell-autonomous manner by activating integrin β1.32 β1 integrin is also involved in a novel form of cognition-related LTP triggered by endogenous cannabinoid signaling in the hippocampus.34 β3 integrins control synaptic strength by influencing alpha-amino-3-hydroxy-5-methylisoxazole-4-proprionate receptor (AMPAR). Under basal activity conditions, β3 integrins promote the internalization of GluA2-containing AMPAR, and after chronic activity stripping, β3 integrins are recruited to the cell surface via postsynaptic tumor necrosis factor signaling.30 The green shaded section contains schizophrenia susceptibility genes (D2 DR, DISC1, NRG1, and ErbB4), which affect synaptic function in multiple ways. Of these, NRG1 can promote GABA release and thus inhibit LTP.37-40 VGCC can interact with postsynaptic NMDAR18 and regulate synaptic plasticity.

Figure 1

Table 1. Distribution and Function of Integrin β in the Cerebral Cortex and Phenotype of Integrin β Subunit Deficient Mice

Figure 2

Figure 2. Schematic representation of the mechanism by which estrogen affects glutamatergic synaptic transmission.E2 binds to the estrogen receptor ER and activates the classical MAPK pathway, causing phosphorylation and activation of the MAPK kinase B-Raf, the MAPK kinases MEK1/2 and the ERK1/2. E2 activates the PI3K signaling pathway, causing activation of phosphoinositide-dependent kinases (PDK1/2) and subsequently AKT/protein kinase B.139 Both signaling pathways can enhance glutamatergic synaptic transmission. The mechanisms involved include increased presynaptic glutamate release probability130,131 and postsynaptic sensitivity to glutamate.131 In addition, E2 is involved in the activation of integrin β1 by acting on Src family kinases and Ras/Rap GTPases. Activated integrin β1 can drive downstream small GTPases that enable local polymerization of filamentous actin (F-actin) from actin monomers (G-actin), thereby affecting AMPAR. Activation of small GTPases can transactivate TrkB, and it has also been speculated that the aforementioned cytoskeletal reorganization also affects TrkB activation.132